Abstract

This study aimed to evaluate the contribution of Machine Learning (ML) approach in the interpretation of intercalating dye-based quantitative PCR (IDqPCR) signals applied to the diagnosis of mucormycosis. The ML-based classification approach was applied to 734 results of IDqPCR categorized as positive (n = 74) or negative (n = 660) for mucormycosis after combining “visual reading” of the amplification and denaturation curves with clinical, radiological and microbiological criteria. Fourteen features were calculated to characterize the curves and injected in several pipelines including four ML-algorithms. An initial subset (n = 345) was used for the conception of classifiers. The classifier predictions were combined with majority voting to estimate performances of 48 meta-classifiers on an external dataset (n = 389). The visual reading returned 57 (7.7%), 568 (77.4%) and 109 (14.8%) positive, negative and doubtful results respectively. The Kappa coefficients of all the meta-classifiers were greater than 0.83 for the classification of IDqPCR results on the external dataset. Among these meta-classifiers, 6 exhibited Kappa coefficients at 1. The proposed ML-based approach allows a rigorous interpretation of IDqPCR curves, making the diagnosis of mucormycosis available for non-specialists in molecular diagnosis. A free online application was developed to classify IDqPCR from the raw data of the thermal cycler output (http://gepamy-sat.asso.st/).

Details

Title
Machine learning to improve the interpretation of intercalating dye-based quantitative PCR results
Author
Godmer, A. 1 ; Bigot, J. 2 ; Giai Gianetto, Q. 3 ; Benzerara, Y. 4 ; Veziris, N. 1 ; Aubry, A. 5 ; Guitard, J. 2 ; Hennequin, C. 2 

 AP-HP, APHP.Sorbonne Université, Hôpital Saint-Antoine, Département de Bactériologie, Paris, France (GRID:grid.412370.3) (ISNI:0000 0004 1937 1100); Sorbonne Université, INSERM, U1135, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657) 
 Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint-Antoine, Service de Parasitologie-Mycologie, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657) 
 Institut Pasteur, Université de Paris, Proteomics Platform, Mass Spectrometry for Biology Unit, UAR CNRS 2024, Paris, France (GRID:grid.462844.8); Institut Pasteur, Université de Paris, Bioinformatics and Biostatistics HUB, Paris, France (GRID:grid.462844.8) 
 AP-HP, APHP.Sorbonne Université, Hôpital Saint-Antoine, Département de Bactériologie, Paris, France (GRID:grid.412370.3) (ISNI:0000 0004 1937 1100) 
 Sorbonne Université, INSERM, U1135, Centre d’Immunologie et des Maladies Infectieuses, Cimi-Paris, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); AP-HP, AP-HP.Sorbonne-Université, Hôpital Pitié-Salpêtrière, Laboratoire de Bactériologie-Hygiène, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2719636205
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.